Fluid Removal vs Circulatory Stability: The Core Trade-off in Haemodialysis

Fluid removal is the central purpose of haemodialysis, yet it is also the main reason patients become unstable during treatment. Every session is a balance between removing enough fluid to reach a safe “dry weight” and maintaining adequate circulation to vital organs. This tension defines the core physiological trade-off in dialysis.

In patients with kidney failure, fluid accumulates between sessions. This excess fluid must be removed through ultrafiltration during dialysis. The challenge is that fluid is being taken directly from the vascular compartment, while the body relies on slower mechanisms to refill that space from the interstitial tissues. If fluid is removed faster than it can be refilled, blood volume drops. When blood volume drops, venous return decreases, cardiac output falls, and blood pressure declines. This is the pathway that leads to intradialytic hypotension.

The body attempts to compensate. The autonomic nervous system increases heart rate and induces vasoconstriction. Hormonal systems such as the renin–angiotensin–aldosterone system and vasopressin are activated. In healthy individuals, these responses can maintain stability. In dialysis patients, these compensatory mechanisms are often impaired. Many patients have autonomic dysfunction, cardiac disease, or vascular stiffness. As a result, the ability to maintain perfusion under stress is limited.

At the same time, dialysis itself introduces additional stressors. Rapid fluid removal reduces plasma volume. Dialysate temperature and composition influence vascular tone. Changes in osmolarity can shift fluid between compartments. All of these factors interact dynamically. What appears to be a simple parameter, the ultrafiltration rate, is actually part of a complex system with delayed and nonlinear responses.

Clinically, this creates a difficult decision. If fluid removal is too aggressive, patients become hypotensive, symptomatic, and at risk of organ hypoperfusion. Repeated episodes are associated with myocardial stunning and potential long-term cardiac injury. If fluid removal is too conservative, patients remain fluid overloaded. Chronic volume overload contributes to hypertension, left ventricular hypertrophy, and increased mortality. There is no static “safe” setting that works for every patient or every session.

This is why the concept of a fixed prescription is inherently limited. Two patients with the same weight gain may tolerate completely different ultrafiltration rates. Even within the same patient, tolerance varies depending on factors such as interdialytic fluid gain, inflammation, medication use, and cardiovascular status on that day. The system is dynamic, but current practice often treats it as static.

In reality, what matters is the relationship between ultrafiltration rate and plasma refill rate. Plasma refill depends on capillary permeability, oncotic pressure, and interstitial fluid availability. These factors are not directly measured in routine care. Clinicians rely on intermittent blood pressure readings and clinical judgement, which means interventions often occur after instability has already developed.

This is where a shift in approach becomes important. Instead of focusing only on how much fluid to remove, the focus should be on how the patient is responding in real time. The key question is no longer “What is the target fluid removal?” but “Is the patient tolerating the current rate, and what will happen next if we continue?”

A predictive approach changes the nature of this trade-off. By analysing continuous data such as blood pressure trends, prior session responses, and machine parameters, it becomes possible to estimate the trajectory of haemodynamic stability. Subtle patterns that precede hypotension can be detected earlier than clinical symptoms. This allows adjustment of ultrafiltration before the critical threshold is crossed.

In this context, fluid removal and circulatory stability are no longer opposing goals managed by trial and error. They become variables that can be dynamically balanced. Fluid can still be removed effectively, but at a rate aligned with the patient’s physiological capacity at that moment.

The future of dialysis lies in managing this balance more intelligently. The trade-off will always exist, but it does not have to be blind. With better insight into patient-specific responses, dialysis can move from reactive correction toward proactive stabilisation, improving both safety and long-term outcomes.